NeurosciencebioRxivPreprint
Rapamycin, an Immunosuppressant and mTORC1 Inhibitor, Triples the antidepressant Response Rate of Ketamine at 2 Weeks Following Treatment: A double-blind, placebo-controlled, cross-over, randomized clinical trial
Chadi G. Abdallah, Lynnette A. Averill, Ralitza V. Gueorguieva…·John Harrison Krystal
This study shows that pretreatment with rapamycin increases the antidepressant response rate of ketamine at 2 weeks but does not affect its acute effects.
30 citations